Salem Investment Counselors’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.21M Sell
126,605
-310
-0.2% -$11.7K 0.13% 99
2026
Q1
$4.54M Buy
126,915
+1,800
+1% +$65.5K 0.13% 96
2025
Q4
$4.06M Buy
125,115
+33,845
+37% +$1.06M 0.11% 105
2025
Q3
$2.58M Sell
91,270
-1,375
-1% -$39.4K 0.07% 138
2025
Q2
$2.79M Buy
92,645
+92,445
+46,223% +$3.13M 0.09% 128
2025
Q1
$8.18K Hold
200
﹤0.01% 864
2024
Q4
$10.8K Buy
+200
New +$11.5K ﹤0.01% 820

Other funds holding CRI

Salem Investment Counselors's CRI Position: Q2 2026 in Review

Salem Investment Counselors reduced its Carter's (CRI) stake by 0.24% in Q2 2026, selling an estimated $11.7K and leaving 126,605 shares worth $5.21M. The position accounts for 0.13% of the portfolio, ranked #99.

Salem Investment Counselors first reported a position in CRI in Q4 2024 and has held it in 7 quarters since. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Salem Investment Counselors held 126,605 shares of Carter's worth $5.21M as of Q2 2026.
  • Salem Investment Counselors sold 310 Carter's shares in Q2 2026, an estimated $11.7K.
  • Carter's made up 0.13% of Salem Investment Counselors's portfolio in Q2 2026, its #99 holding.
  • Salem Investment Counselors first reported a position in Carter's in Q4 2024 and has held it in 7 quarters since.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.